Vimarsana
Biggest News Aggregation in the World

Karnofsky Performance Scale News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Karnofsky Performance Scale. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Karnofsky Performance Scale Today - Breaking & Trending Today

Geriatric Assessment Measures Predict Chemotherapy Toxicity, NHL Survival - Vimarsana News

Geriatric Assessment Measures Predict Chemotherapy Toxicity, NHL Survival

Timed Up and Go geriatric assessment test significantly correlated with chemotherapy toxicity events in older patients with advanced lymphoma.

Belzutifan Generates Superior PFS, ORR in Pretreated Advanced ccRCC - Vimarsana News

Belzutifan Generates Superior PFS, ORR in Pretreated Advanced ccRCC

Treatment with belzutifan produced improvements in progression-free survival and objective response rate vs everolimus in patients with pretreated advanced clear cell renal cell carcinoma.

New Regimen for GvHD Prophylaxis in Well-Matched Reduced-Intensity Allo-HCT - Vimarsana News

New Regimen for GvHD Prophylaxis in Well-Matched Reduced-Intensity Allo-HCT

Post-transplant cyclophosphamide, tacrolimus, and MMF reduces GvHD without higher relapse risk

Risk of COVID-19 and Poor Outcomes Not Increased Among Glioma Patients - Vimarsana News

Risk of COVID-19 and Poor Outcomes Not Increased Among Glioma Patients

Patients with glioma do not have an increased risk of SARS-CoV-2 infection or worse outcomes from COVID-19, a single-center study suggests.

Risk of COVID-19 and Poor Outcomes Not Increased Among Glioma Patients - Vimarsana News

Risk of COVID-19 and Poor Outcomes Not Increased Among Glioma Patients

Patients with glioma do not have an increased risk of SARS-CoV-2 infection or worse outcomes from COVID-19, a single-center study suggests.